These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 19639202)

  • 21. Antitumor effects of the novel NF-kappaB inhibitor dehydroxymethyl-epoxyquinomicin on human hepatic cancer cells: analysis of synergy with cisplatin and of possible correlation with inhibition of pro-survival genes and IL-6 production.
    Poma P; Notarbartolo M; Labbozzetta M; Sanguedolce R; Alaimo A; Carina V; Maurici A; Cusimano A; Cervello M; D'Alessandro N
    Int J Oncol; 2006 Apr; 28(4):923-30. PubMed ID: 16525642
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of NF-kappaB and human telomerase reverse transcriptase in gastric cancer and precancerous lesions.
    Wang W; Luo HS; Yu BP
    World J Gastroenterol; 2004 Jan; 10(2):177-81. PubMed ID: 14716817
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cell cycle-specific changes in hTERT promoter activity in normal and cancerous cells in adenoviral gene therapy: a promising implication of telomerase-dependent targeted cancer gene therapy.
    Murofushi Y; Nagano S; Kamizono J; Takahashi T; Fujiwara H; Komiya S; Matsuishi T; Kosai K
    Int J Oncol; 2006 Sep; 29(3):681-8. PubMed ID: 16865285
    [TBL] [Abstract][Full Text] [Related]  

  • 24. RNA interference-mediated hTERT inhibition enhances TRAIL-induced apoptosis in resistant hepatocellular carcinoma cells.
    Zhang RG; Zhao JJ; Yang LQ; Yang SM; Wang RQ; Chen WS; Peng GY; Fang DC
    Oncol Rep; 2010 Apr; 23(4):1013-9. PubMed ID: 20204286
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of the JNK signaling pathway increases sensitivity of hepatocellular carcinoma cells to cisplatin by down-regulating expression of P-glycoprotein.
    Liu XY; Liu SP; Jiang J; Zhang X; Zhang T
    Eur Rev Med Pharmacol Sci; 2016; 20(6):1098-108. PubMed ID: 27049263
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ad-mTERT-delta19, a conditional replication-competent adenovirus driven by the human telomerase promoter, selectively replicates in and elicits cytopathic effect in a cancer cell-specific manner.
    Kim E; Kim JH; Shin HY; Lee H; Yang JM; Kim J; Sohn JH; Kim H; Yun CO
    Hum Gene Ther; 2003 Oct; 14(15):1415-28. PubMed ID: 14577922
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nuclear factor kappa B-mediated CD47 up-regulation promotes sorafenib resistance and its blockade synergizes the effect of sorafenib in hepatocellular carcinoma in mice.
    Lo J; Lau EY; Ching RH; Cheng BY; Ma MK; Ng IO; Lee TK
    Hepatology; 2015 Aug; 62(2):534-45. PubMed ID: 25902734
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of hepatitis B virus X protein on human telomerase reverse transcriptase expression and activity in hepatoma cells.
    Zhang X; Dong N; Zhang H; You J; Wang H; Ye L
    J Lab Clin Med; 2005 Feb; 145(2):98-104. PubMed ID: 15746653
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Induction of apoptotic endonuclease EndoG with DNA-damaging agents initiates alternative splicing of telomerase catalytic subunit hTERT and inhibition of telomerase activity hTERT in human CD4+ and CD8+ T-lymphocytes].
    Zhdanov DD; Vasina DA; Orlova VS; Orlova EV; Grishin DV; Gladilina YA; Pokrovskaya MV; Aleksandrova SS; Sokolov NN
    Biomed Khim; 2017 Jul; 63(4):296-305. PubMed ID: 28862599
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Upregulated miR-182 increases drug resistance in cisplatin-treated HCC cell by regulating TP53INP1.
    Qin J; Luo M; Qian H; Chen W
    Gene; 2014 Apr; 538(2):342-7. PubMed ID: 24447717
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combination of caspase transfer using the human telomerase reverse transcriptase promoter and conventional therapies for malignant glioma cells.
    Takeuchi H; Kanzawa T; Kondo Y; Komata T; Hirohata S; Kyo S; Kondo S
    Int J Oncol; 2004 Jul; 25(1):57-63. PubMed ID: 15201989
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human telomerase reverse transcriptase promoter regulation in normal and malignant human ovarian epithelial cells.
    Braunstein I; Cohen-Barak O; Shachaf C; Ravel Y; Yalon-Hacohen M; Mills GB; Tzukerman M; Skorecki KL
    Cancer Res; 2001 Jul; 61(14):5529-36. PubMed ID: 11454703
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Knockdown of mutated H-Ras V12 expression induces chemosensitivity of hepatocellular carcinoma cells to cisplatin treatment in vitro and in nude mouse xenografts.
    Meng F; Cao B; Feng Z; Ma S; Wang H; Li Y; Li H
    Oncol Rep; 2014 Nov; 32(5):2023-30. PubMed ID: 25189269
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hexabromocyclododecane and polychlorinated biphenyls increase resistance of hepatocellular carcinoma cells to cisplatin through the phosphatidylinositol 3-kinase/protein kinase B pathway.
    An J; Wang X; Guo P; Zhong Y; Zhang X; Yu Z
    Toxicol Lett; 2014 Aug; 229(1):265-72. PubMed ID: 24960055
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cisplatin-induced apoptotic endonuclease EndoG inhibits telomerase activity and causes malignant transformation of human CD4+ T lymphocytes].
    Zhdanov DD; Vasina DА; Orlova EV; Orlova VS; Pokrovsky VS; Pokrovskaya MV; Aleksandrova SS; Sokolov NN
    Biomed Khim; 2017 Jan; 63(1):13-26. PubMed ID: 28251947
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlation between chemosensitivity to anticancer drugs and telomerase reverse transcriptase mRNA expression in gastric cancer.
    Wang L; Li PF; Geng M; Cao YC; Yin YC
    Diagn Pathol; 2013 Feb; 8():33. PubMed ID: 23432846
    [TBL] [Abstract][Full Text] [Related]  

  • 37. siRNA suppression of hTERT using activatable cell-penetrating peptides in hepatoma cells.
    Li H; He J; Yi H; Xiang G; Chen K; Fu B; Yang Y; Chen G
    Biosci Rep; 2015 Mar; 35(2):. PubMed ID: 25671640
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transcriptional regulation of the telomerase hTERT gene as a target for cellular and viral oncogenic mechanisms.
    Horikawa I; Barrett JC
    Carcinogenesis; 2003 Jul; 24(7):1167-76. PubMed ID: 12807729
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low-dose etoposide enhances telomerase-dependent adenovirus-mediated cytosine deaminase gene therapy through augmentation of adenoviral infection and transgene expression in a syngeneic bladder tumor model.
    Shieh GS; Shiau AL; Yo YT; Lin PR; Chang CC; Tzai TS; Wu CL
    Cancer Res; 2006 Oct; 66(20):9957-66. PubMed ID: 17047058
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Telomere dysfunction increases cisplatin and ecteinascidin-743 sensitivity of melanoma cells.
    Biroccio A; Gabellini C; Amodei S; Benassi B; Del Bufalo D; Elli R; Antonelli A; D'Incalci M; Zupi G
    Mol Pharmacol; 2003 Mar; 63(3):632-8. PubMed ID: 12606771
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.